Skip to main content

Table 1 Genotypes and phenotypes of thalassaemia

From: Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition

 

VariantVariant

GenotypeGenotype

Phenotype

β-thalassaemia

Normal

αα/αα

Normal

 

Silent Carrier

-α/αα

Haematologically silent or mild reduction of MCH/MCV

 

Minor

-α/-α , - -/αα

Borderline anaemia or normal, as well as microcytic and hypochromic red blood cells

 

HbH disease*

- -/-α , - -/αTα, αTα/αTα T - -/- - T α T α

Majority have mild to moderate anaemia and marked microcytosis and hypochromia, only few have phenotype similar to thalassaemia major

 

Barts Hydrops Foetalis

- -/- -

Most develop hydrops foetalis syndrome and die in utero, or shortly after birth

β-thalassaemia

Normal

β/β

Normal

 

Minor

β/β++ , β/β00

Borderline anaemia or normal as well as microcytic and hypochromic red blood cells

 

β-thalassaemia intermedia*

β + /β + ,β 0 /β + , β + /β, β 0 /β, β 0 /β 0

Severity is very variable. Clinical picture ranges from mild to moderate NTDT

 

Major

β0β0 , β0/β+

Severe anaemia requiring regular transfusions (TDT)

HbE

HbE trait

βE/β

Asymptomatic condition with no clinical relevance

 

Homozygous HbE

βE/βE

Usually asymptomatic with borderline asymptomatic anaemia and no haemolysis

 

HbE/ β-thalassaemia*

β E /β + ,β E /β 0

Severity is very variable. Clinical picture ranges from NTDT to TDT

 

HbE/HbS

βE/βS

Similar to sickle cell disease usually with rare vaso-occlusive crisis

  1. *Thalassaemia genotypes that often result in NTDT.